Advertisement

Index by author

January 01, 2018; Volume 46,Issue 1

A

  1. Abdelwahed, Ramadan

    1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib
      Waleed Elsayed Ahmed Ellawatty, Yusuke Masuo, Ken-ichi Fujita, Erina Yamazaki, Hiroo Ishida, Hiroshi Arakawa, Noritaka Nakamichi, Ramadan Abdelwahed, Yasutsuna Sasaki and Yukio Kato
      Drug Metabolism and Disposition January 2018, 46 (1) 33-40; DOI: https://doi.org/10.1124/dmd.117.076554

  2. Andrabi, Shaida A.

    1. Generation and Characterization of SULT4A1 Mutant Mouse Models
      Patrick L. Garcia, Mohammed I. Hossain, Shaida A. Andrabi and Charles N. Falany
      Drug Metabolism and Disposition January 2018, 46 (1) 41-45; DOI: https://doi.org/10.1124/dmd.117.077560

  3. Arakawa, Hiroshi

    1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib
      Waleed Elsayed Ahmed Ellawatty, Yusuke Masuo, Ken-ichi Fujita, Erina Yamazaki, Hiroo Ishida, Hiroshi Arakawa, Noritaka Nakamichi, Ramadan Abdelwahed, Yasutsuna Sasaki and Yukio Kato
      Drug Metabolism and Disposition January 2018, 46 (1) 33-40; DOI: https://doi.org/10.1124/dmd.117.076554

B

  1. Bukuroshi, Paola

    1. Highlighting Vitamin D Receptor–Targeted Activities of 1α,25-Dihydroxyvitamin D3 in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling
      Qi Joy Yang, Paola Bukuroshi, Holly P. Quach, Edwin C. Y. Chow and K. Sandy Pang
      Drug Metabolism and Disposition January 2018, 46 (1) 75-87; DOI: https://doi.org/10.1124/dmd.117.077271

C

  1. Chen, Huimin

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

  2. Chow, Edwin C. Y.

    1. Highlighting Vitamin D Receptor–Targeted Activities of 1α,25-Dihydroxyvitamin D3 in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling
      Qi Joy Yang, Paola Bukuroshi, Holly P. Quach, Edwin C. Y. Chow and K. Sandy Pang
      Drug Metabolism and Disposition January 2018, 46 (1) 75-87; DOI: https://doi.org/10.1124/dmd.117.077271

  3. Chun, Dung Yu

    1. Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches
      Ramachandra Sangana, Helen Gu, Dung Yu Chun and Heidi J. Einolf
      Drug Metabolism and Disposition January 2018, 46 (1) 26-32; DOI: https://doi.org/10.1124/dmd.117.077834

D

  1. Duan, Zhijian

    1. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijian Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
      Drug Metabolism and Disposition January 2018, 46 (1) 2-10; DOI: https://doi.org/10.1124/dmd.117.078741

E

  1. Einolf, Heidi J.

    1. Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches
      Ramachandra Sangana, Helen Gu, Dung Yu Chun and Heidi J. Einolf
      Drug Metabolism and Disposition January 2018, 46 (1) 26-32; DOI: https://doi.org/10.1124/dmd.117.077834

  2. Ellawatty, Waleed Elsayed Ahmed

    1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib
      Waleed Elsayed Ahmed Ellawatty, Yusuke Masuo, Ken-ichi Fujita, Erina Yamazaki, Hiroo Ishida, Hiroshi Arakawa, Noritaka Nakamichi, Ramadan Abdelwahed, Yasutsuna Sasaki and Yukio Kato
      Drug Metabolism and Disposition January 2018, 46 (1) 33-40; DOI: https://doi.org/10.1124/dmd.117.076554

F

  1. Falany, Charles N.

    1. Generation and Characterization of SULT4A1 Mutant Mouse Models
      Patrick L. Garcia, Mohammed I. Hossain, Shaida A. Andrabi and Charles N. Falany
      Drug Metabolism and Disposition January 2018, 46 (1) 41-45; DOI: https://doi.org/10.1124/dmd.117.077560

  2. Fennema, Diede

    1. Open Access
      Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine N-oxide Production, Plasma Cholesterol Concentration, and an Index of Atherosclerosis
      Sunil Veeravalli, Kersti Karu, Flora Scott, Diede Fennema, Ian R. Phillips and Elizabeth A. Shephard
      Drug Metabolism and Disposition January 2018, 46 (1) 20-25; DOI: https://doi.org/10.1124/dmd.117.077636

  3. Fujita, Ken-ichi

    1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib
      Waleed Elsayed Ahmed Ellawatty, Yusuke Masuo, Ken-ichi Fujita, Erina Yamazaki, Hiroo Ishida, Hiroshi Arakawa, Noritaka Nakamichi, Ramadan Abdelwahed, Yasutsuna Sasaki and Yukio Kato
      Drug Metabolism and Disposition January 2018, 46 (1) 33-40; DOI: https://doi.org/10.1124/dmd.117.076554

G

  1. Garcia, Patrick L.

    1. Generation and Characterization of SULT4A1 Mutant Mouse Models
      Patrick L. Garcia, Mohammed I. Hossain, Shaida A. Andrabi and Charles N. Falany
      Drug Metabolism and Disposition January 2018, 46 (1) 41-45; DOI: https://doi.org/10.1124/dmd.117.077560

  2. Gu, Helen

    1. Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches
      Ramachandra Sangana, Helen Gu, Dung Yu Chun and Heidi J. Einolf
      Drug Metabolism and Disposition January 2018, 46 (1) 26-32; DOI: https://doi.org/10.1124/dmd.117.077834

H

  1. Hayashi, Ryoji

    1. Organic Anion–Transporting Polypeptide (OATP)–Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver
      Masashi Uchida, Yoriko Tajima, Masakazu Kakuni, Yutaka Kageyama, Taro Okada, Eri Sakurada, Chise Tateno and Ryoji Hayashi
      Drug Metabolism and Disposition January 2018, 46 (1) 11-19; DOI: https://doi.org/10.1124/dmd.117.075994

  2. Ho, Pui Yan

    1. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijian Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
      Drug Metabolism and Disposition January 2018, 46 (1) 2-10; DOI: https://doi.org/10.1124/dmd.117.078741

  3. Hossain, Mohammed I.

    1. Generation and Characterization of SULT4A1 Mutant Mouse Models
      Patrick L. Garcia, Mohammed I. Hossain, Shaida A. Andrabi and Charles N. Falany
      Drug Metabolism and Disposition January 2018, 46 (1) 41-45; DOI: https://doi.org/10.1124/dmd.117.077560

I

  1. Inouye, Yoshio

    1. Tripartite Motif Containing 24 Acts as a Novel Coactivator of the Constitutive Active/Androstane Receptor
      Yuichiro Kanno, Yuki Kure, Saori Kobayashi, Mariko Mizuno, Yumi Tsuchiya, Naoya Yamashita, Kiyomitsu Nemoto and Yoshio Inouye
      Drug Metabolism and Disposition January 2018, 46 (1) 46-52; DOI: https://doi.org/10.1124/dmd.117.077693

  2. Ishida, Hiroo

    1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib
      Waleed Elsayed Ahmed Ellawatty, Yusuke Masuo, Ken-ichi Fujita, Erina Yamazaki, Hiroo Ishida, Hiroshi Arakawa, Noritaka Nakamichi, Ramadan Abdelwahed, Yasutsuna Sasaki and Yukio Kato
      Drug Metabolism and Disposition January 2018, 46 (1) 33-40; DOI: https://doi.org/10.1124/dmd.117.076554

  3. Ishida, Kazuya

    1. Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics
      Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz and Jashvant D. Unadkat
      Drug Metabolism and Disposition January 2018, 46 (1) 66-74; DOI: https://doi.org/10.1124/dmd.117.076539

J

  1. Jilek, Joseph L.

    1. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijian Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
      Drug Metabolism and Disposition January 2018, 46 (1) 2-10; DOI: https://doi.org/10.1124/dmd.117.078741

  2. Juhasz, Viktoria

    1. Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics
      Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz and Jashvant D. Unadkat
      Drug Metabolism and Disposition January 2018, 46 (1) 66-74; DOI: https://doi.org/10.1124/dmd.117.076539

K

  1. Kageyama, Yutaka

    1. Organic Anion–Transporting Polypeptide (OATP)–Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver
      Masashi Uchida, Yoriko Tajima, Masakazu Kakuni, Yutaka Kageyama, Taro Okada, Eri Sakurada, Chise Tateno and Ryoji Hayashi
      Drug Metabolism and Disposition January 2018, 46 (1) 11-19; DOI: https://doi.org/10.1124/dmd.117.075994

  2. Kakuni, Masakazu

    1. Organic Anion–Transporting Polypeptide (OATP)–Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver
      Masashi Uchida, Yoriko Tajima, Masakazu Kakuni, Yutaka Kageyama, Taro Okada, Eri Sakurada, Chise Tateno and Ryoji Hayashi
      Drug Metabolism and Disposition January 2018, 46 (1) 11-19; DOI: https://doi.org/10.1124/dmd.117.075994

  3. Kang, Dian

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

  4. Kanno, Yuichiro

    1. Tripartite Motif Containing 24 Acts as a Novel Coactivator of the Constitutive Active/Androstane Receptor
      Yuichiro Kanno, Yuki Kure, Saori Kobayashi, Mariko Mizuno, Yumi Tsuchiya, Naoya Yamashita, Kiyomitsu Nemoto and Yoshio Inouye
      Drug Metabolism and Disposition January 2018, 46 (1) 46-52; DOI: https://doi.org/10.1124/dmd.117.077693

  5. Karu, Kersti

    1. Open Access
      Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine N-oxide Production, Plasma Cholesterol Concentration, and an Index of Atherosclerosis
      Sunil Veeravalli, Kersti Karu, Flora Scott, Diede Fennema, Ian R. Phillips and Elizabeth A. Shephard
      Drug Metabolism and Disposition January 2018, 46 (1) 20-25; DOI: https://doi.org/10.1124/dmd.117.077636

  6. Kato, Yukio

    1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib
      Waleed Elsayed Ahmed Ellawatty, Yusuke Masuo, Ken-ichi Fujita, Erina Yamazaki, Hiroo Ishida, Hiroshi Arakawa, Noritaka Nakamichi, Ramadan Abdelwahed, Yasutsuna Sasaki and Yukio Kato
      Drug Metabolism and Disposition January 2018, 46 (1) 33-40; DOI: https://doi.org/10.1124/dmd.117.076554

  7. Kobayashi, Saori

    1. Tripartite Motif Containing 24 Acts as a Novel Coactivator of the Constitutive Active/Androstane Receptor
      Yuichiro Kanno, Yuki Kure, Saori Kobayashi, Mariko Mizuno, Yumi Tsuchiya, Naoya Yamashita, Kiyomitsu Nemoto and Yoshio Inouye
      Drug Metabolism and Disposition January 2018, 46 (1) 46-52; DOI: https://doi.org/10.1124/dmd.117.077693

  8. Kure, Yuki

    1. Tripartite Motif Containing 24 Acts as a Novel Coactivator of the Constitutive Active/Androstane Receptor
      Yuichiro Kanno, Yuki Kure, Saori Kobayashi, Mariko Mizuno, Yumi Tsuchiya, Naoya Yamashita, Kiyomitsu Nemoto and Yoshio Inouye
      Drug Metabolism and Disposition January 2018, 46 (1) 46-52; DOI: https://doi.org/10.1124/dmd.117.077693

L

  1. Li, Haofeng

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

  2. Li, Peng-Cheng

    1. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijian Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
      Drug Metabolism and Disposition January 2018, 46 (1) 2-10; DOI: https://doi.org/10.1124/dmd.117.078741

  3. Li, Xinuo

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

  4. Liang, Yan

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

M

  1. Masuo, Yusuke

    1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib
      Waleed Elsayed Ahmed Ellawatty, Yusuke Masuo, Ken-ichi Fujita, Erina Yamazaki, Hiroo Ishida, Hiroshi Arakawa, Noritaka Nakamichi, Ramadan Abdelwahed, Yasutsuna Sasaki and Yukio Kato
      Drug Metabolism and Disposition January 2018, 46 (1) 33-40; DOI: https://doi.org/10.1124/dmd.117.076554

  2. Mizuno, Mariko

    1. Tripartite Motif Containing 24 Acts as a Novel Coactivator of the Constitutive Active/Androstane Receptor
      Yuichiro Kanno, Yuki Kure, Saori Kobayashi, Mariko Mizuno, Yumi Tsuchiya, Naoya Yamashita, Kiyomitsu Nemoto and Yoshio Inouye
      Drug Metabolism and Disposition January 2018, 46 (1) 46-52; DOI: https://doi.org/10.1124/dmd.117.077693

N

  1. Nakamichi, Noritaka

    1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib
      Waleed Elsayed Ahmed Ellawatty, Yusuke Masuo, Ken-ichi Fujita, Erina Yamazaki, Hiroo Ishida, Hiroshi Arakawa, Noritaka Nakamichi, Ramadan Abdelwahed, Yasutsuna Sasaki and Yukio Kato
      Drug Metabolism and Disposition January 2018, 46 (1) 33-40; DOI: https://doi.org/10.1124/dmd.117.076554

  2. Nemoto, Kiyomitsu

    1. Tripartite Motif Containing 24 Acts as a Novel Coactivator of the Constitutive Active/Androstane Receptor
      Yuichiro Kanno, Yuki Kure, Saori Kobayashi, Mariko Mizuno, Yumi Tsuchiya, Naoya Yamashita, Kiyomitsu Nemoto and Yoshio Inouye
      Drug Metabolism and Disposition January 2018, 46 (1) 46-52; DOI: https://doi.org/10.1124/dmd.117.077693

O

  1. Okada, Taro

    1. Organic Anion–Transporting Polypeptide (OATP)–Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver
      Masashi Uchida, Yoriko Tajima, Masakazu Kakuni, Yutaka Kageyama, Taro Okada, Eri Sakurada, Chise Tateno and Ryoji Hayashi
      Drug Metabolism and Disposition January 2018, 46 (1) 11-19; DOI: https://doi.org/10.1124/dmd.117.075994

P

  1. Pang, K. Sandy

    1. Highlighting Vitamin D Receptor–Targeted Activities of 1α,25-Dihydroxyvitamin D3 in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling
      Qi Joy Yang, Paola Bukuroshi, Holly P. Quach, Edwin C. Y. Chow and K. Sandy Pang
      Drug Metabolism and Disposition January 2018, 46 (1) 75-87; DOI: https://doi.org/10.1124/dmd.117.077271

  2. Phillips, Ian R.

    1. Open Access
      Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine N-oxide Production, Plasma Cholesterol Concentration, and an Index of Atherosclerosis
      Sunil Veeravalli, Kersti Karu, Flora Scott, Diede Fennema, Ian R. Phillips and Elizabeth A. Shephard
      Drug Metabolism and Disposition January 2018, 46 (1) 20-25; DOI: https://doi.org/10.1124/dmd.117.077636

Q

  1. Quach, Holly P.

    1. Highlighting Vitamin D Receptor–Targeted Activities of 1α,25-Dihydroxyvitamin D3 in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling
      Qi Joy Yang, Paola Bukuroshi, Holly P. Quach, Edwin C. Y. Chow and K. Sandy Pang
      Drug Metabolism and Disposition January 2018, 46 (1) 75-87; DOI: https://doi.org/10.1124/dmd.117.077271

S

  1. Sakurada, Eri

    1. Organic Anion–Transporting Polypeptide (OATP)–Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver
      Masashi Uchida, Yoriko Tajima, Masakazu Kakuni, Yutaka Kageyama, Taro Okada, Eri Sakurada, Chise Tateno and Ryoji Hayashi
      Drug Metabolism and Disposition January 2018, 46 (1) 11-19; DOI: https://doi.org/10.1124/dmd.117.075994

  2. Sangana, Ramachandra

    1. Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches
      Ramachandra Sangana, Helen Gu, Dung Yu Chun and Heidi J. Einolf
      Drug Metabolism and Disposition January 2018, 46 (1) 26-32; DOI: https://doi.org/10.1124/dmd.117.077834

  3. Sasaki, Yasutsuna

    1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib
      Waleed Elsayed Ahmed Ellawatty, Yusuke Masuo, Ken-ichi Fujita, Erina Yamazaki, Hiroo Ishida, Hiroshi Arakawa, Noritaka Nakamichi, Ramadan Abdelwahed, Yasutsuna Sasaki and Yukio Kato
      Drug Metabolism and Disposition January 2018, 46 (1) 33-40; DOI: https://doi.org/10.1124/dmd.117.076554

  4. Scott, Flora

    1. Open Access
      Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine N-oxide Production, Plasma Cholesterol Concentration, and an Index of Atherosclerosis
      Sunil Veeravalli, Kersti Karu, Flora Scott, Diede Fennema, Ian R. Phillips and Elizabeth A. Shephard
      Drug Metabolism and Disposition January 2018, 46 (1) 20-25; DOI: https://doi.org/10.1124/dmd.117.077636

  5. Shao, Yuhao

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

  6. Shen, Boyu

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

  7. Shephard, Elizabeth A.

    1. Open Access
      Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine N-oxide Production, Plasma Cholesterol Concentration, and an Index of Atherosclerosis
      Sunil Veeravalli, Kersti Karu, Flora Scott, Diede Fennema, Ian R. Phillips and Elizabeth A. Shephard
      Drug Metabolism and Disposition January 2018, 46 (1) 20-25; DOI: https://doi.org/10.1124/dmd.117.077636

T

  1. Tajima, Yoriko

    1. Organic Anion–Transporting Polypeptide (OATP)–Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver
      Masashi Uchida, Yoriko Tajima, Masakazu Kakuni, Yutaka Kageyama, Taro Okada, Eri Sakurada, Chise Tateno and Ryoji Hayashi
      Drug Metabolism and Disposition January 2018, 46 (1) 11-19; DOI: https://doi.org/10.1124/dmd.117.075994

  2. Tateno, Chise

    1. Organic Anion–Transporting Polypeptide (OATP)–Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver
      Masashi Uchida, Yoriko Tajima, Masakazu Kakuni, Yutaka Kageyama, Taro Okada, Eri Sakurada, Chise Tateno and Ryoji Hayashi
      Drug Metabolism and Disposition January 2018, 46 (1) 11-19; DOI: https://doi.org/10.1124/dmd.117.075994

  3. Tóth, Beáta

    1. Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics
      Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz and Jashvant D. Unadkat
      Drug Metabolism and Disposition January 2018, 46 (1) 66-74; DOI: https://doi.org/10.1124/dmd.117.076539

  4. Tsuchiya, Yumi

    1. Tripartite Motif Containing 24 Acts as a Novel Coactivator of the Constitutive Active/Androstane Receptor
      Yuichiro Kanno, Yuki Kure, Saori Kobayashi, Mariko Mizuno, Yumi Tsuchiya, Naoya Yamashita, Kiyomitsu Nemoto and Yoshio Inouye
      Drug Metabolism and Disposition January 2018, 46 (1) 46-52; DOI: https://doi.org/10.1124/dmd.117.077693

  5. Tu, Mei-Juan

    1. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijian Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
      Drug Metabolism and Disposition January 2018, 46 (1) 2-10; DOI: https://doi.org/10.1124/dmd.117.078741

U

  1. Uchida, Masashi

    1. Organic Anion–Transporting Polypeptide (OATP)–Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver
      Masashi Uchida, Yoriko Tajima, Masakazu Kakuni, Yutaka Kageyama, Taro Okada, Eri Sakurada, Chise Tateno and Ryoji Hayashi
      Drug Metabolism and Disposition January 2018, 46 (1) 11-19; DOI: https://doi.org/10.1124/dmd.117.075994

  2. Ullah, Mohammed

    1. Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics
      Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz and Jashvant D. Unadkat
      Drug Metabolism and Disposition January 2018, 46 (1) 66-74; DOI: https://doi.org/10.1124/dmd.117.076539

  3. Unadkat, Jashvant D.

    1. Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics
      Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz and Jashvant D. Unadkat
      Drug Metabolism and Disposition January 2018, 46 (1) 66-74; DOI: https://doi.org/10.1124/dmd.117.076539

V

  1. Veeravalli, Sunil

    1. Open Access
      Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine N-oxide Production, Plasma Cholesterol Concentration, and an Index of Atherosclerosis
      Sunil Veeravalli, Kersti Karu, Flora Scott, Diede Fennema, Ian R. Phillips and Elizabeth A. Shephard
      Drug Metabolism and Disposition January 2018, 46 (1) 20-25; DOI: https://doi.org/10.1124/dmd.117.077636

W

  1. Wang, Guangji

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

X

  1. Xiao, Jingcheng

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

  2. Xie, Lin

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

Y

  1. Yamashita, Naoya

    1. Tripartite Motif Containing 24 Acts as a Novel Coactivator of the Constitutive Active/Androstane Receptor
      Yuichiro Kanno, Yuki Kure, Saori Kobayashi, Mariko Mizuno, Yumi Tsuchiya, Naoya Yamashita, Kiyomitsu Nemoto and Yoshio Inouye
      Drug Metabolism and Disposition January 2018, 46 (1) 46-52; DOI: https://doi.org/10.1124/dmd.117.077693

  2. Yamazaki, Erina

    1. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib
      Waleed Elsayed Ahmed Ellawatty, Yusuke Masuo, Ken-ichi Fujita, Erina Yamazaki, Hiroo Ishida, Hiroshi Arakawa, Noritaka Nakamichi, Ramadan Abdelwahed, Yasutsuna Sasaki and Yukio Kato
      Drug Metabolism and Disposition January 2018, 46 (1) 33-40; DOI: https://doi.org/10.1124/dmd.117.076554

  3. Yang, Qi Joy

    1. Highlighting Vitamin D Receptor–Targeted Activities of 1α,25-Dihydroxyvitamin D3 in Mice via Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling
      Qi Joy Yang, Paola Bukuroshi, Holly P. Quach, Edwin C. Y. Chow and K. Sandy Pang
      Drug Metabolism and Disposition January 2018, 46 (1) 75-87; DOI: https://doi.org/10.1124/dmd.117.077271

  4. Yin, Xiaoxi

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436

  5. Yu, Ai-Ming

    1. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijian Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
      Drug Metabolism and Disposition January 2018, 46 (1) 2-10; DOI: https://doi.org/10.1124/dmd.117.078741

  6. Yu, Ai-Xi

    1. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijian Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
      Drug Metabolism and Disposition January 2018, 46 (1) 2-10; DOI: https://doi.org/10.1124/dmd.117.078741

Z

  1. Zhang, Qian-Yu

    1. Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Bioengineered NRF2-siRNA Is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells
      Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijian Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
      Drug Metabolism and Disposition January 2018, 46 (1) 2-10; DOI: https://doi.org/10.1124/dmd.117.078741

  2. Zhu, Zhangpei

    1. Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Low Cerebral Exposure Cannot Hinder the Neuroprotective Effects of Panax Notoginsenosides
      Haofeng Li, Jingcheng Xiao, Xinuo Li, Huimin Chen, Dian Kang, Yuhao Shao, Boyu Shen, Zhangpei Zhu, Xiaoxi Yin, Lin Xie, Guangji Wang and Yan Liang
      Drug Metabolism and Disposition January 2018, 46 (1) 53-65; DOI: https://doi.org/10.1124/dmd.117.078436
Back to top

In this issue

Advertisement